Cargando…
Predictive factor for the response to adjuvant therapy with emphasis in breast cancer
One of the major challenges of early-stage breast cancer is to select the adjuvant therapy that ensures the most benefits and the least harm for the patient. The definition of accurate predictive factors is therefore of paramount importance. So far the choice of adjuvant therapy has been based on th...
Autores principales: | Munster, Pamela N, Norton, Larry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138701/ https://www.ncbi.nlm.nih.gov/pubmed/11737886 http://dx.doi.org/10.1186/bcr323 |
Ejemplares similares
-
Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007) -
The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor–Positive Breast Cancer
por: Lohmann, Ana Elisa, et al.
Publicado: (2022) -
Dose-dense adjuvant chemotherapy for primary breast cancer
por: Fornier, Monica, et al.
Publicado: (2005) -
Is it Possible to Predict Benefit from 5FU Adjuvant Therapy in Stage III Colon Cancer Patients?
por: Bonin, Serena
Publicado: (2015) -
Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer
por: Ferrer, Gerardo, et al.
Publicado: (2022)